Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling
Cells · 05.03.2024 · 13 (5) · 455
DOI: 10.3390/cells13050455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 05.03.2024. Verfasst von Jing Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg. 10-CRC, Room 5-33…. Hauptthemen laut MEDLINE: Dinoprostone, Sirtuin 3, Pyridinium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Intramural NIH HHS, Medical Research Council.
Abstract (Originalsprache)
NAD+ boosting via nicotinamide riboside (NR) confers anti-inflammatory effects. However, its underlying mechanisms and therapeutic potential remain incompletely defined. Here, we showed that NR increased the expression of CC-chemokine receptor 7 (CCR7) in human M1 macrophages by flow cytometric analysis of cell surface receptors. Consequently, chemokine ligand 19 (CCL19, ligand for CCR7)-induced macrophage migration was enhanced following NR administration. Metabolomics analysis revealed that prostaglandin E2 (PGE2) was increased by NR in human monocytes and in human serum following in vivo NR supplementation. Furthermore, NR-mediated upregulation of macrophage migration through CCL19/CCR7 was dependent on PGE2 synthesis. We also demonstrated that NR upregulated PGE2 synthesis through SIRT3-dependent post-transcriptional regulation of cyclooxygenase 2 (COX-2). The NR/SIRT3/migration axis was further validated using the scratch-test model where NR and SIRT3 promoted more robust migration across a uniformly disrupted macrophage monolayer. Thus, NR-mediated metabolic regulation of macrophage migration and wound healing may have therapeutic potential for the topical management of chronic wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg. 10-CRC, Room 5-3342, 10 Center Drive, Bethesda, MD 20892, USA.
- Department of Biochemistry, Cambridge University, Cambridge CB2 1QW, UK.
- Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
- The Rowett Institute, School of Medicine, Medical Sciences and Nutrition, Foresterhill Campus, Aberdeen AB25 2ZD, UK.
ORCID-Profile: Russell S Steans
Förderung
- NHLBI NIH HHS
- Intramural NIH HHS
- Medical Research Council
- NIH HHS
- NHLBI Division of Intramural Research
- UK MRC
Zitieren
APA
Wu, J., Bley, M., Steans, R. S., Meadows, A. M., Huffstutler, R. D., Tian, R., Griffin, J. L., & Sack, M. N. (2024). Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling. Cells, 13(5), 455. https://doi.org/10.3390/cells13050455
Vancouver
Wu J, Bley M, Steans RS, Meadows AM, Huffstutler RD, Tian R, et al. Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling. Cells. 2024;13(5):455. doi:10.3390/cells13050455
BibTeX
@article{Wu2024,
author = {Wu, Jing and Bley, Maximilian and Steans, Russell S and Meadows, Allison M and Huffstutler, Rebecca D and Tian, Rong and Griffin, Julian L and Sack, Michael N},
title = {Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling},
journal = {Cells},
year = {2024},
volume = {13},
number = {5},
pages = {455},
doi = {10.3390/cells13050455}
}
EUVIMED